Bibombe Patrice Mwipatayi

Dr. Bibombe Patrice Mwipatayi


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2011 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
BMBibombe Patrice Mwipatayi
Bibombe Patrice Mwipatayi
STShannon Thomas
Shannon Thomas
JWJackie Wong
Jackie Wong
STSuzanna E.L. Temple
Suzanna E.L. Temple
VVVikram Vijayan
Vikram Vijayan
SBSally A. Burrows
Sally A. Burrows

1 July 2016 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
BMBibombe Patrice Mwipatayi
Bibombe Patrice Mwipatayi
SSSurabhi Sharma
Surabhi Sharma
ADAli Daneshmand
Ali Daneshmand
STShannon D. Thomas
Shannon D. Thomas
VVVikram Vijayan
Vikram Vijayan
JFJohn Fletcher
John Fletcher

17 March 2005 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
BMBibombe Patrice Mwipatayi
Bibombe Patrice Mwipatayi
PJPeter C. Jeffery
Peter C. Jeffery
SBSteve J. Beningfield
Steve J. Beningfield
PMPhilip J. Matley
Philip J. Matley
NNNaid G. Naidoo
Naid G. Naidoo
DKDel Kahn
Del Kahn

20 September 2021 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
MDMichael D. Dake
Michael D. Dake
GOGerard O’sUllivan
Gerard O’sUllivan
NSNicolas W. Shammas
Nicolas W. Shammas
MLMichael Lichtenberg
Michael Lichtenberg
BMBibombe Patrice Mwipatayi
Bibombe Patrice Mwipatayi
FIfor the VERNACULAR Trial Investigators
for the VERNACULAR Trial Investigators
Purpose: To assess safety and patency of the Venovo venous stent for the treatment of iliofemoral vein obstruction. Materials and Methods: Twenty-two international centers enrolled 170 patients in the VERNACULAR study (93 post-thrombotic syndrome; 77 non-thrombotic iliac vein lesions). Primary outcome measures were major adverse events at 30 days and 12-month primary patency (freedom from target vessel revascularization, thrombotic occlusion, or stenosis > 50%). Secondary outcomes included the Venous Clinical Severity Score Pain Assessment and Chronic Venous Quality-of-Life Questionnaire assessments (hypothesis tested). Secondary observations included primary patency, target vessel and lesion revascularization (TVR/TLR), and assessment of stent integrity through 36 months. Results: Freedom from major adverse events through 30 days was 93.5%, statistically higher than a pre-specified performance goal of 89% (p = 0.032) while primary patency at 12 months was 88.6%, also statistically higher than a performance goal of 74% (p < 0.0001). Mean quality-of-life measures were statistically improved compared to baseline values at 12 months (p < 0.0001). Primary patency at 36 months was 84% (Kaplan–Meier analysis) while freedom from TVR/TLR was 88.1%. There was no stent embolization/migration, and no core laboratory assessed stent fractures reported through 36 months. Six deaths were reported; none adjudicated as device or procedure related. Conclusion: The Venovo venous stent was successfully deployed in obstructive iliofemoral vein lesions and met the pre-specified primary outcome measures through 12 months. At 3 years, primary patency was 84%, reintervention rates were low, standardized quality-of-life and pain measures improved from baseline, and there was no stent migration or fractures. Level of Evidence: Level 2—prospective, multicenter, controlled clinical study without a concurrent control or randomization. Pre-specified endpoints were hypothesis-tested to performance goals derived from peer-reviewed clinical literature. Registration clinicaltrials.gov: Unique Identifier NCT02655887.

1 May 2015 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
EFElsa Madeleine Faure
Elsa Madeleine Faure
JBJean-Pierre Becquemin
Jean-Pierre Becquemin
FCFrederic Cochennec
Frederic Cochennec
RMRicardo Garcia Monaco
Ricardo Garcia Monaco
MFMariano Ferreira
Mariano Ferreira
CGCarmelo Gastambide
Carmelo Gastambide

24 May 2006 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
TLTao S. Lim
Tao S. Lim
AFAndrew Finlayson
Andrew Finlayson
JTJames M. Thorpe
James M. Thorpe
KSKishore Sieunarine
Kishore Sieunarine
BMBibombe Patrice Mwipatayi
Bibombe Patrice Mwipatayi
DADonna Angel
Donna Angel